Ampio Pharmaceuticals Company Profile (NASDAQ:AMPE)

About Ampio Pharmaceuticals (NASDAQ:AMPE)

Ampio Pharmaceuticals logoAmpio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AMPE
  • CUSIP: N/A
  • Web:
  • Market Cap: $74.37 million
  • Outstanding Shares: 68,232,000
Average Prices:
  • 50 Day Moving Avg: $0.72
  • 200 Day Moving Avg: $0.63
  • 52 Week Range: $0.38 - $1.34
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.74
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $0.05 per share
  • Price / Book: 21.80
  • EBITDA: ($12,770,000.00)
  • Return on Equity: -239.01%
  • Return on Assets: -87.54%
  • Average Volume: 525,363 shs.
  • Short Ratio: 15.47

Frequently Asked Questions for Ampio Pharmaceuticals (NASDAQ:AMPE)

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMPE."

Who are some of Ampio Pharmaceuticals' key competitors?

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the folowing people:

  • Michael Macaluso, Chairman of the Board, Chief Executive Officer
  • Thomas E. Chilcott III, Chief Financial Officer
  • Holli Cherevka, Chief Operating Officer
  • David Bar-Or M.D., Chief Scientific Officer, Director
  • Gregory A. Gould CPA, Treasurer, Secretary
  • Vaughan Lennox Clift M.D., Chief Regulatory Affairs Officer
  • Philip H. Coelho M.D., Independent Director
  • Richard B. Giles, Independent Director
  • David R. Stevens Ph.D., Independent Director

How do I buy Ampio Pharmaceuticals stock?

Shares of Ampio Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of Ampio Pharmaceuticals stock can currently be purchased for approximately $1.09.

MarketBeat Community Rating for Ampio Pharmaceuticals (NASDAQ AMPE)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  13
MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Ampio Pharmaceuticals (NASDAQ:AMPE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Ampio Pharmaceuticals (NASDAQ:AMPE)
Price Target History for Ampio Pharmaceuticals (NASDAQ:AMPE)
Analysts' Ratings History for Ampio Pharmaceuticals (NASDAQ:AMPE)
No equities research coverage for this company has been tracked by


Earnings History for Ampio Pharmaceuticals (NASDAQ:AMPE)
No earnings announcements for this company have been tracked by


Earnings Estimates for Ampio Pharmaceuticals (NASDAQ:AMPE)
Current Year EPS Consensus Estimate: $-0.61 EPS
Next Year EPS Consensus Estimate: $-0.19 EPS


Dividend History for Ampio Pharmaceuticals (NASDAQ:AMPE)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Ampio Pharmaceuticals (NASDAQ:AMPE)
Insider Trades by Quarter for Ampio Pharmaceuticals (NASDAQ:AMPE)
Insider Trades by Quarter for Ampio Pharmaceuticals (NASDAQ:AMPE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/27/2017Philip H CoelhoDirectorBuy10,000$0.63$6,300.00View SEC Filing  
9/22/2017Philip H CoelhoDirectorBuy3,000$0.60$1,800.00View SEC Filing  
9/20/2017Philip H CoelhoDirectorBuy1,000$0.59$590.00View SEC Filing  
9/19/2017Philip H CoelhoDirectorBuy15,000$0.57$8,550.00View SEC Filing  
9/5/2017Philip H CoelhoDirectorBuy30,000$0.56$16,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Ampio Pharmaceuticals (NASDAQ:AMPE)
Latest Headlines for Ampio Pharmaceuticals (NASDAQ:AMPE)
Loading headlines, please wait.



Ampio Pharmaceuticals (AMPE) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.